nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—Nateglinide—type 2 diabetes mellitus	0.215	0.622	CrCtD
Cilazapril—Ramipril—type 2 diabetes mellitus	0.13	0.378	CrCtD
Cilazapril—ACE—type 2 diabetes mellitus	0.112	1	CbGaD
Cilazapril—ACE—Ramipril—type 2 diabetes mellitus	0.034	0.152	CbGbCtD
Cilazapril—ACE—Losartan—type 2 diabetes mellitus	0.02	0.0893	CbGbCtD
Cilazapril—Mitiglinide—Nateglinide—type 2 diabetes mellitus	0.02	0.0886	CrCrCtD
Cilazapril—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0199	0.0888	CbGbCtD
Cilazapril—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0178	0.0792	CbGbCtD
Cilazapril—Spirapril—Nateglinide—type 2 diabetes mellitus	0.0173	0.0766	CrCrCtD
Cilazapril—Lisinopril—Nateglinide—type 2 diabetes mellitus	0.0173	0.0766	CrCrCtD
Cilazapril—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0172	0.0765	CbGbCtD
Cilazapril—Trandolapril—Nateglinide—type 2 diabetes mellitus	0.0162	0.0718	CrCrCtD
Cilazapril—Ramipril—Nateglinide—type 2 diabetes mellitus	0.0162	0.0718	CrCrCtD
Cilazapril—Enalapril—Nateglinide—type 2 diabetes mellitus	0.0162	0.0718	CrCrCtD
Cilazapril—Perindopril—Ramipril—type 2 diabetes mellitus	0.0162	0.0717	CrCrCtD
Cilazapril—Fosinopril—Ramipril—type 2 diabetes mellitus	0.0162	0.0717	CrCrCtD
Cilazapril—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0158	0.0706	CbGbCtD
Cilazapril—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0153	0.0682	CbGbCtD
Cilazapril—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0151	0.0673	CbGbCtD
Cilazapril—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0136	0.0608	CbGbCtD
Cilazapril—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.013	0.058	CbGbCtD
Cilazapril—Moexipril—Ramipril—type 2 diabetes mellitus	0.0122	0.0539	CrCrCtD
Cilazapril—Mitiglinide—Ramipril—type 2 diabetes mellitus	0.0122	0.0539	CrCrCtD
Cilazapril—Spirapril—Ramipril—type 2 diabetes mellitus	0.0105	0.0466	CrCrCtD
Cilazapril—Lisinopril—Ramipril—type 2 diabetes mellitus	0.0105	0.0466	CrCrCtD
Cilazapril—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0102	0.0455	CbGbCtD
Cilazapril—Trandolapril—Ramipril—type 2 diabetes mellitus	0.00985	0.0437	CrCrCtD
Cilazapril—Enalapril—Ramipril—type 2 diabetes mellitus	0.00985	0.0437	CrCrCtD
Cilazapril—Nateglinide—Ramipril—type 2 diabetes mellitus	0.00879	0.039	CrCrCtD
Cilazapril—SLC15A1—Glyburide—type 2 diabetes mellitus	0.00879	0.0392	CbGbCtD
Cilazapril—Quinapril—Ramipril—type 2 diabetes mellitus	0.00835	0.037	CrCrCtD
Cilazapril—Benazepril—Ramipril—type 2 diabetes mellitus	0.00795	0.0352	CrCrCtD
Cilazapril—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00654	0.0291	CbGbCtD
Cilazapril—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00583	0.026	CbGbCtD
Cilazapril—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00421	0.0188	CbGbCtD
Cilazapril—ACE—arteriole—type 2 diabetes mellitus	0.00305	0.156	CbGeAlD
Cilazapril—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00289	0.0129	CbGbCtD
Cilazapril—ACE—forelimb zeugopod—type 2 diabetes mellitus	0.00267	0.137	CbGeAlD
Cilazapril—ACE—tunica intima—type 2 diabetes mellitus	0.00216	0.111	CbGeAlD
Cilazapril—ABCB1—Glyburide—type 2 diabetes mellitus	0.00216	0.00961	CbGbCtD
Cilazapril—ABCB1—Losartan—type 2 diabetes mellitus	0.00197	0.00879	CbGbCtD
Cilazapril—ACE—sympathetic nervous system—type 2 diabetes mellitus	0.00194	0.0994	CbGeAlD
Cilazapril—ACE—autonomic nervous system—type 2 diabetes mellitus	0.00131	0.0668	CbGeAlD
Cilazapril—ACE—hindlimb—type 2 diabetes mellitus	0.00121	0.0618	CbGeAlD
Cilazapril—ACE—peripheral nervous system—type 2 diabetes mellitus	0.000942	0.0482	CbGeAlD
Cilazapril—ACE—artery—type 2 diabetes mellitus	0.00074	0.0379	CbGeAlD
Cilazapril—ACE—nerve—type 2 diabetes mellitus	0.000734	0.0376	CbGeAlD
Cilazapril—ACE—endothelium—type 2 diabetes mellitus	0.000625	0.032	CbGeAlD
Cilazapril—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000399	0.0204	CbGeAlD
Cilazapril—SLC15A1—kidney—type 2 diabetes mellitus	0.000351	0.018	CbGeAlD
Cilazapril—ACE—nephron tubule—type 2 diabetes mellitus	0.000286	0.0147	CbGeAlD
Cilazapril—SLC15A2—retina—type 2 diabetes mellitus	0.000265	0.0136	CbGeAlD
Cilazapril—ACE—cardiovascular system—type 2 diabetes mellitus	0.000257	0.0132	CbGeAlD
Cilazapril—ACE—kidney—type 2 diabetes mellitus	0.000252	0.0129	CbGeAlD
Cilazapril—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.00025	0.0128	CbGeAlD
Cilazapril—ACE—cortex of kidney—type 2 diabetes mellitus	0.000245	0.0125	CbGeAlD
Cilazapril—ACE—adipose tissue—type 2 diabetes mellitus	0.000227	0.0116	CbGeAlD
Cilazapril—SLC15A1—liver—type 2 diabetes mellitus	0.000222	0.0114	CbGeAlD
Cilazapril—SLC15A2—kidney—type 2 diabetes mellitus	0.000219	0.0112	CbGeAlD
Cilazapril—Mitiglinide—ABCC8—type 2 diabetes mellitus	0.000216	0.132	CrCbGaD
Cilazapril—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.000214	0.0109	CbGeAlD
Cilazapril—ACE—liver—type 2 diabetes mellitus	0.000159	0.00814	CbGeAlD
Cilazapril—Mitiglinide—KCNJ11—type 2 diabetes mellitus	0.000152	0.093	CrCbGaD
Cilazapril—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000125	0.00641	CbGeAlD
Cilazapril—Nateglinide—ABCC8—type 2 diabetes mellitus	0.00011	0.0672	CrCbGaD
Cilazapril—Fosinopril—ACE—type 2 diabetes mellitus	0.000109	0.0669	CrCbGaD
Cilazapril—ABCB1—retina—type 2 diabetes mellitus	0.000107	0.00548	CbGeAlD
Cilazapril—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000101	0.00516	CbGeAlD
Cilazapril—ABCB1—cardiovascular system—type 2 diabetes mellitus	9.05e-05	0.00463	CbGeAlD
Cilazapril—Perindopril—ACE—type 2 diabetes mellitus	8.92e-05	0.0546	CrCbGaD
Cilazapril—ABCB1—kidney—type 2 diabetes mellitus	8.86e-05	0.00453	CbGeAlD
Cilazapril—Spirapril—ACE—type 2 diabetes mellitus	8.82e-05	0.0539	CrCbGaD
Cilazapril—ABCB1—pancreas—type 2 diabetes mellitus	8.8e-05	0.0045	CbGeAlD
Cilazapril—ABCB1—cortex of kidney—type 2 diabetes mellitus	8.63e-05	0.00442	CbGeAlD
Cilazapril—Moexipril—ACE—type 2 diabetes mellitus	8.46e-05	0.0517	CrCbGaD
Cilazapril—Mitiglinide—PPARG—type 2 diabetes mellitus	8.43e-05	0.0515	CrCbGaD
Cilazapril—Benazepril—MTHFR—type 2 diabetes mellitus	8.39e-05	0.0513	CrCbGaD
Cilazapril—ABCB1—adipose tissue—type 2 diabetes mellitus	7.98e-05	0.00409	CbGeAlD
Cilazapril—Quinapril—ACE—type 2 diabetes mellitus	7.87e-05	0.0481	CrCbGaD
Cilazapril—Lisinopril—ACE—type 2 diabetes mellitus	7.87e-05	0.0481	CrCbGaD
Cilazapril—Nateglinide—KCNJ11—type 2 diabetes mellitus	7.75e-05	0.0474	CrCbGaD
Cilazapril—Ramipril—ACE—type 2 diabetes mellitus	7.62e-05	0.0466	CrCbGaD
Cilazapril—Trandolapril—ACE—type 2 diabetes mellitus	7.62e-05	0.0466	CrCbGaD
Cilazapril—Benazepril—ACE—type 2 diabetes mellitus	6.84e-05	0.0418	CrCbGaD
Cilazapril—Enalapril—ACE—type 2 diabetes mellitus	5.77e-05	0.0353	CrCbGaD
Cilazapril—ABCB1—liver—type 2 diabetes mellitus	5.6e-05	0.00287	CbGeAlD
Cilazapril—Nateglinide—PPARG—type 2 diabetes mellitus	4.29e-05	0.0262	CrCbGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	4.16e-05	0.00435	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	4.05e-05	0.00424	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—DPP4—type 2 diabetes mellitus	4.05e-05	0.00424	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	4.02e-05	0.0042	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—GIP—type 2 diabetes mellitus	3.9e-05	0.00408	CbGpPWpGaD
Cilazapril—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	3.87e-05	0.00405	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	3.77e-05	0.00394	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	3.65e-05	0.00382	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	3.6e-05	0.00377	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	3.54e-05	0.0037	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	3.44e-05	0.0036	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	3.41e-05	0.00357	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	3.41e-05	0.00357	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	3.36e-05	0.00351	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	3.34e-05	0.0035	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—HNF4A—type 2 diabetes mellitus	3.32e-05	0.00347	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	3.28e-05	0.00343	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—GCK—type 2 diabetes mellitus	3.23e-05	0.00338	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	3.19e-05	0.00334	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	3.17e-05	0.00332	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	3.17e-05	0.00332	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	3.12e-05	0.00327	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	3.12e-05	0.00326	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	2.96e-05	0.0031	CbGpPWpGaD
Cilazapril—Oedema—Metformin—type 2 diabetes mellitus	2.91e-05	0.000467	CcSEcCtD
Cilazapril—Tinnitus—Ramipril—type 2 diabetes mellitus	2.91e-05	0.000467	CcSEcCtD
Cilazapril—Hypertension—Irbesartan—type 2 diabetes mellitus	2.91e-05	0.000467	CcSEcCtD
Cilazapril—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	2.9e-05	0.000466	CcSEcCtD
Cilazapril—Flushing—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000465	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.9e-05	0.00303	CbGpPWpGaD
Cilazapril—Angioedema—Losartan—type 2 diabetes mellitus	2.9e-05	0.000465	CcSEcCtD
Cilazapril—Insomnia—Valsartan—type 2 diabetes mellitus	2.89e-05	0.000464	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	2.88e-05	0.000462	CcSEcCtD
Cilazapril—Paraesthesia—Valsartan—type 2 diabetes mellitus	2.87e-05	0.000461	CcSEcCtD
Cilazapril—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	2.87e-05	0.00046	CcSEcCtD
Cilazapril—Myalgia—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.00046	CcSEcCtD
Cilazapril—Chest pain—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.00046	CcSEcCtD
Cilazapril—Arthralgia—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.00046	CcSEcCtD
Cilazapril—Shock—Metformin—type 2 diabetes mellitus	2.87e-05	0.00046	CcSEcCtD
Cilazapril—Insomnia—Orlistat—type 2 diabetes mellitus	2.86e-05	0.000459	CcSEcCtD
Cilazapril—Malaise—Losartan—type 2 diabetes mellitus	2.86e-05	0.000459	CcSEcCtD
Cilazapril—Anxiety—Irbesartan—type 2 diabetes mellitus	2.86e-05	0.000459	CcSEcCtD
Cilazapril—Hypersensitivity—Glyburide—type 2 diabetes mellitus	2.86e-05	0.000458	CcSEcCtD
Cilazapril—Thrombocytopenia—Metformin—type 2 diabetes mellitus	2.85e-05	0.000458	CcSEcCtD
Cilazapril—Dyspnoea—Valsartan—type 2 diabetes mellitus	2.85e-05	0.000458	CcSEcCtD
Cilazapril—Vertigo—Losartan—type 2 diabetes mellitus	2.85e-05	0.000457	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	2.85e-05	0.000457	CcSEcCtD
Cilazapril—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	2.85e-05	0.000457	CcSEcCtD
Cilazapril—Somnolence—Valsartan—type 2 diabetes mellitus	2.84e-05	0.000456	CcSEcCtD
Cilazapril—Syncope—Losartan—type 2 diabetes mellitus	2.84e-05	0.000456	CcSEcCtD
Cilazapril—Paraesthesia—Orlistat—type 2 diabetes mellitus	2.84e-05	0.000455	CcSEcCtD
Cilazapril—Leukopenia—Losartan—type 2 diabetes mellitus	2.84e-05	0.000455	CcSEcCtD
Cilazapril—Discomfort—Irbesartan—type 2 diabetes mellitus	2.83e-05	0.000455	CcSEcCtD
Cilazapril—Skin disorder—Metformin—type 2 diabetes mellitus	2.83e-05	0.000454	CcSEcCtD
Cilazapril—Immune system disorder—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000452	CcSEcCtD
Cilazapril—Hyperhidrosis—Metformin—type 2 diabetes mellitus	2.82e-05	0.000452	CcSEcCtD
Cilazapril—Dyspepsia—Valsartan—type 2 diabetes mellitus	2.82e-05	0.000452	CcSEcCtD
Cilazapril—Dizziness—Bromocriptine—type 2 diabetes mellitus	2.81e-05	0.00045	CcSEcCtD
Cilazapril—Dry mouth—Irbesartan—type 2 diabetes mellitus	2.81e-05	0.00045	CcSEcCtD
Cilazapril—Palpitations—Losartan—type 2 diabetes mellitus	2.8e-05	0.000449	CcSEcCtD
Cilazapril—Nausea—Glimepiride—type 2 diabetes mellitus	2.79e-05	0.000448	CcSEcCtD
Cilazapril—Arrhythmia—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000448	CcSEcCtD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.79e-05	0.00292	CbGpPWpGaD
Cilazapril—Loss of consciousness—Losartan—type 2 diabetes mellitus	2.79e-05	0.000447	CcSEcCtD
Cilazapril—Nausea—Sitagliptin—type 2 diabetes mellitus	2.78e-05	0.000447	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.78e-05	0.00291	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.78e-05	0.00291	CbGpPWpGaD
Cilazapril—Dyspepsia—Orlistat—type 2 diabetes mellitus	2.78e-05	0.000446	CcSEcCtD
Cilazapril—Asthenia—Glyburide—type 2 diabetes mellitus	2.78e-05	0.000446	CcSEcCtD
Cilazapril—Decreased appetite—Valsartan—type 2 diabetes mellitus	2.78e-05	0.000446	CcSEcCtD
Cilazapril—Anorexia—Metformin—type 2 diabetes mellitus	2.78e-05	0.000446	CcSEcCtD
Cilazapril—Cough—Losartan—type 2 diabetes mellitus	2.77e-05	0.000444	CcSEcCtD
Cilazapril—Urticaria—Gliclazide—type 2 diabetes mellitus	2.77e-05	0.000444	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	2.76e-05	0.000443	CcSEcCtD
Cilazapril—Alopecia—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000443	CcSEcCtD
Cilazapril—Fatigue—Valsartan—type 2 diabetes mellitus	2.76e-05	0.000442	CcSEcCtD
Cilazapril—Abdominal pain—Gliclazide—type 2 diabetes mellitus	2.75e-05	0.000442	CcSEcCtD
Cilazapril—Oedema—Irbesartan—type 2 diabetes mellitus	2.75e-05	0.000441	CcSEcCtD
Cilazapril—Decreased appetite—Orlistat—type 2 diabetes mellitus	2.75e-05	0.000441	CcSEcCtD
Cilazapril—Pruritus—Glyburide—type 2 diabetes mellitus	2.74e-05	0.00044	CcSEcCtD
Cilazapril—Constipation—Valsartan—type 2 diabetes mellitus	2.74e-05	0.000439	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	2.73e-05	0.000438	CcSEcCtD
Cilazapril—Fatigue—Orlistat—type 2 diabetes mellitus	2.73e-05	0.000437	CcSEcCtD
Cilazapril—Hypotension—Metformin—type 2 diabetes mellitus	2.72e-05	0.000437	CcSEcCtD
Cilazapril—Enalapril—CYP3A4—type 2 diabetes mellitus	2.71e-05	0.0166	CrCbGaD
Cilazapril—Shock—Irbesartan—type 2 diabetes mellitus	2.71e-05	0.000434	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	2.7e-05	0.00283	CbGpPWpGaD
Cilazapril—Pain—Orlistat—type 2 diabetes mellitus	2.7e-05	0.000434	CcSEcCtD
Cilazapril—Chest pain—Losartan—type 2 diabetes mellitus	2.7e-05	0.000433	CcSEcCtD
Cilazapril—Arthralgia—Losartan—type 2 diabetes mellitus	2.7e-05	0.000433	CcSEcCtD
Cilazapril—Myalgia—Losartan—type 2 diabetes mellitus	2.7e-05	0.000433	CcSEcCtD
Cilazapril—Vomiting—Bromocriptine—type 2 diabetes mellitus	2.7e-05	0.000433	CcSEcCtD
Cilazapril—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	2.69e-05	0.000432	CcSEcCtD
Cilazapril—Anxiety—Losartan—type 2 diabetes mellitus	2.69e-05	0.000431	CcSEcCtD
Cilazapril—Tachycardia—Irbesartan—type 2 diabetes mellitus	2.68e-05	0.00043	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.68e-05	0.0028	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.68e-05	0.0028	CbGpPWpGaD
Cilazapril—Rash—Bromocriptine—type 2 diabetes mellitus	2.67e-05	0.000429	CcSEcCtD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.67e-05	0.0028	CbGpPWpGaD
Cilazapril—Dermatitis—Bromocriptine—type 2 diabetes mellitus	2.67e-05	0.000429	CcSEcCtD
Cilazapril—Skin disorder—Irbesartan—type 2 diabetes mellitus	2.67e-05	0.000428	CcSEcCtD
Cilazapril—Tension—Ramipril—type 2 diabetes mellitus	2.67e-05	0.000428	CcSEcCtD
Cilazapril—Discomfort—Losartan—type 2 diabetes mellitus	2.67e-05	0.000428	CcSEcCtD
Cilazapril—Dysgeusia—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000427	CcSEcCtD
Cilazapril—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	2.66e-05	0.000426	CcSEcCtD
Cilazapril—Headache—Bromocriptine—type 2 diabetes mellitus	2.66e-05	0.000426	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	2.65e-05	0.000426	CcSEcCtD
Cilazapril—ABCB1—ABC-family proteins mediated transport—APOA1—type 2 diabetes mellitus	2.65e-05	0.00278	CbGpPWpGaD
Cilazapril—Diarrhoea—Glyburide—type 2 diabetes mellitus	2.65e-05	0.000426	CcSEcCtD
Cilazapril—Nervousness—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000424	CcSEcCtD
Cilazapril—Dry mouth—Losartan—type 2 diabetes mellitus	2.64e-05	0.000423	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.63e-05	0.00275	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—type 2 diabetes mellitus	2.62e-05	0.00274	CbGpPWpGaD
Cilazapril—Anorexia—Irbesartan—type 2 diabetes mellitus	2.62e-05	0.00042	CcSEcCtD
Cilazapril—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	2.62e-05	0.00042	CcSEcCtD
Cilazapril—Paraesthesia—Metformin—type 2 diabetes mellitus	2.62e-05	0.00042	CcSEcCtD
Cilazapril—Muscle spasms—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000419	CcSEcCtD
Cilazapril—Confusional state—Losartan—type 2 diabetes mellitus	2.61e-05	0.000419	CcSEcCtD
Cilazapril—Feeling abnormal—Orlistat—type 2 diabetes mellitus	2.61e-05	0.000418	CcSEcCtD
Cilazapril—Dyspnoea—Metformin—type 2 diabetes mellitus	2.6e-05	0.000417	CcSEcCtD
Cilazapril—Somnolence—Metformin—type 2 diabetes mellitus	2.59e-05	0.000415	CcSEcCtD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.59e-05	0.00271	CbGpPWpGaD
Cilazapril—Oedema—Losartan—type 2 diabetes mellitus	2.59e-05	0.000415	CcSEcCtD
Cilazapril—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	2.59e-05	0.000415	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.58e-05	0.0027	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.58e-05	0.0027	CbGpPWpGaD
Cilazapril—Hypotension—Irbesartan—type 2 diabetes mellitus	2.57e-05	0.000412	CcSEcCtD
Cilazapril—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	2.57e-05	0.000412	CcSEcCtD
Cilazapril—Dyspepsia—Metformin—type 2 diabetes mellitus	2.56e-05	0.000411	CcSEcCtD
Cilazapril—Tremor—Ramipril—type 2 diabetes mellitus	2.55e-05	0.000409	CcSEcCtD
Cilazapril—Shock—Losartan—type 2 diabetes mellitus	2.55e-05	0.000408	CcSEcCtD
Cilazapril—Urticaria—Valsartan—type 2 diabetes mellitus	2.54e-05	0.000408	CcSEcCtD
Cilazapril—Thrombocytopenia—Losartan—type 2 diabetes mellitus	2.53e-05	0.000406	CcSEcCtD
Cilazapril—Decreased appetite—Metformin—type 2 diabetes mellitus	2.53e-05	0.000406	CcSEcCtD
Cilazapril—Abdominal pain—Valsartan—type 2 diabetes mellitus	2.53e-05	0.000406	CcSEcCtD
Cilazapril—Tachycardia—Losartan—type 2 diabetes mellitus	2.53e-05	0.000405	CcSEcCtD
Cilazapril—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000405	CcSEcCtD
Cilazapril—Nausea—Bromocriptine—type 2 diabetes mellitus	2.52e-05	0.000404	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	2.52e-05	0.000404	CcSEcCtD
Cilazapril—Fatigue—Metformin—type 2 diabetes mellitus	2.51e-05	0.000403	CcSEcCtD
Cilazapril—Urticaria—Orlistat—type 2 diabetes mellitus	2.51e-05	0.000403	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.51e-05	0.000402	CcSEcCtD
Cilazapril—Hyperhidrosis—Losartan—type 2 diabetes mellitus	2.5e-05	0.000401	CcSEcCtD
Cilazapril—Abdominal pain—Orlistat—type 2 diabetes mellitus	2.5e-05	0.000401	CcSEcCtD
Cilazapril—Asthenia—Gliclazide—type 2 diabetes mellitus	2.5e-05	0.000401	CcSEcCtD
Cilazapril—Constipation—Metformin—type 2 diabetes mellitus	2.49e-05	0.0004	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.49e-05	0.0026	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.49e-05	0.0026	CbGpPWpGaD
Cilazapril—Angioedema—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000398	CcSEcCtD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.48e-05	0.0026	CbGpPWpGaD
Cilazapril—Paraesthesia—Irbesartan—type 2 diabetes mellitus	2.47e-05	0.000396	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—type 2 diabetes mellitus	2.47e-05	0.00258	CbGpPWpGaD
Cilazapril—Anorexia—Losartan—type 2 diabetes mellitus	2.47e-05	0.000396	CcSEcCtD
Cilazapril—Vomiting—Glyburide—type 2 diabetes mellitus	2.47e-05	0.000396	CcSEcCtD
Cilazapril—Pruritus—Gliclazide—type 2 diabetes mellitus	2.46e-05	0.000395	CcSEcCtD
Cilazapril—Malaise—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000393	CcSEcCtD
Cilazapril—Dyspnoea—Irbesartan—type 2 diabetes mellitus	2.45e-05	0.000393	CcSEcCtD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	2.45e-05	0.00256	CbGpPWpGaD
Cilazapril—Rash—Glyburide—type 2 diabetes mellitus	2.45e-05	0.000392	CcSEcCtD
Cilazapril—Somnolence—Irbesartan—type 2 diabetes mellitus	2.44e-05	0.000392	CcSEcCtD
Cilazapril—Dermatitis—Glyburide—type 2 diabetes mellitus	2.44e-05	0.000392	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.44e-05	0.00256	CbGpPWpGaD
Cilazapril—Vertigo—Ramipril—type 2 diabetes mellitus	2.44e-05	0.000392	CcSEcCtD
Cilazapril—Syncope—Ramipril—type 2 diabetes mellitus	2.44e-05	0.000391	CcSEcCtD
Cilazapril—Leukopenia—Ramipril—type 2 diabetes mellitus	2.43e-05	0.00039	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.43e-05	0.00255	CbGpPWpGaD
Cilazapril—Headache—Glyburide—type 2 diabetes mellitus	2.43e-05	0.00039	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—F7—type 2 diabetes mellitus	2.43e-05	0.00254	CbGpPWpGaD
Cilazapril—Dyspepsia—Irbesartan—type 2 diabetes mellitus	2.42e-05	0.000388	CcSEcCtD
Cilazapril—Hypotension—Losartan—type 2 diabetes mellitus	2.42e-05	0.000388	CcSEcCtD
Cilazapril—Palpitations—Ramipril—type 2 diabetes mellitus	2.4e-05	0.000385	CcSEcCtD
Cilazapril—Feeling abnormal—Metformin—type 2 diabetes mellitus	2.4e-05	0.000385	CcSEcCtD
Cilazapril—Decreased appetite—Irbesartan—type 2 diabetes mellitus	2.39e-05	0.000383	CcSEcCtD
Cilazapril—Loss of consciousness—Ramipril—type 2 diabetes mellitus	2.39e-05	0.000383	CcSEcCtD
Cilazapril—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.38e-05	0.000382	CcSEcCtD
Cilazapril—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.38e-05	0.000382	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	2.37e-05	0.000381	CcSEcCtD
Cilazapril—Cough—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000381	CcSEcCtD
Cilazapril—Fatigue—Irbesartan—type 2 diabetes mellitus	2.37e-05	0.00038	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	2.36e-05	0.00247	CbGpPWpGaD
Cilazapril—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.36e-05	0.000378	CcSEcCtD
Cilazapril—Hypersensitivity—Valsartan—type 2 diabetes mellitus	2.36e-05	0.000378	CcSEcCtD
Cilazapril—Pain—Irbesartan—type 2 diabetes mellitus	2.35e-05	0.000377	CcSEcCtD
Cilazapril—Constipation—Irbesartan—type 2 diabetes mellitus	2.35e-05	0.000377	CcSEcCtD
Cilazapril—Insomnia—Losartan—type 2 diabetes mellitus	2.34e-05	0.000375	CcSEcCtD
Cilazapril—Hypersensitivity—Orlistat—type 2 diabetes mellitus	2.33e-05	0.000374	CcSEcCtD
Cilazapril—Paraesthesia—Losartan—type 2 diabetes mellitus	2.32e-05	0.000373	CcSEcCtD
Cilazapril—Urticaria—Metformin—type 2 diabetes mellitus	2.31e-05	0.000371	CcSEcCtD
Cilazapril—Chest pain—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000371	CcSEcCtD
Cilazapril—Arthralgia—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000371	CcSEcCtD
Cilazapril—Myalgia—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000371	CcSEcCtD
Cilazapril—Dyspnoea—Losartan—type 2 diabetes mellitus	2.31e-05	0.00037	CcSEcCtD
Cilazapril—Anxiety—Ramipril—type 2 diabetes mellitus	2.31e-05	0.00037	CcSEcCtD
Cilazapril—Nausea—Glyburide—type 2 diabetes mellitus	2.3e-05	0.00037	CcSEcCtD
Cilazapril—Abdominal pain—Metformin—type 2 diabetes mellitus	2.3e-05	0.000369	CcSEcCtD
Cilazapril—Dizziness—Gliclazide—type 2 diabetes mellitus	2.3e-05	0.000369	CcSEcCtD
Cilazapril—Somnolence—Losartan—type 2 diabetes mellitus	2.3e-05	0.000369	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	2.3e-05	0.000369	CcSEcCtD
Cilazapril—Asthenia—Valsartan—type 2 diabetes mellitus	2.3e-05	0.000368	CcSEcCtD
Cilazapril—Discomfort—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000367	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.28e-05	0.00238	CbGpPWpGaD
Cilazapril—Dyspepsia—Losartan—type 2 diabetes mellitus	2.28e-05	0.000365	CcSEcCtD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	2.27e-05	0.00238	CbGpPWpGaD
Cilazapril—Asthenia—Orlistat—type 2 diabetes mellitus	2.27e-05	0.000364	CcSEcCtD
Cilazapril—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.27e-05	0.000363	CcSEcCtD
Cilazapril—Pruritus—Valsartan—type 2 diabetes mellitus	2.26e-05	0.000363	CcSEcCtD
Cilazapril—Dry mouth—Ramipril—type 2 diabetes mellitus	2.26e-05	0.000363	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.26e-05	0.00236	CbGpPWpGaD
Cilazapril—Decreased appetite—Losartan—type 2 diabetes mellitus	2.25e-05	0.000361	CcSEcCtD
Cilazapril—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.25e-05	0.000361	CcSEcCtD
Cilazapril—Confusional state—Ramipril—type 2 diabetes mellitus	2.24e-05	0.000359	CcSEcCtD
Cilazapril—Pruritus—Orlistat—type 2 diabetes mellitus	2.24e-05	0.000359	CcSEcCtD
Cilazapril—Fatigue—Losartan—type 2 diabetes mellitus	2.23e-05	0.000358	CcSEcCtD
Cilazapril—Oedema—Ramipril—type 2 diabetes mellitus	2.22e-05	0.000356	CcSEcCtD
Cilazapril—Vomiting—Gliclazide—type 2 diabetes mellitus	2.21e-05	0.000355	CcSEcCtD
Cilazapril—Constipation—Losartan—type 2 diabetes mellitus	2.21e-05	0.000355	CcSEcCtD
Cilazapril—Pain—Losartan—type 2 diabetes mellitus	2.21e-05	0.000355	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.2e-05	0.0023	CbGpPWpGaD
Cilazapril—Rash—Gliclazide—type 2 diabetes mellitus	2.2e-05	0.000352	CcSEcCtD
Cilazapril—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.19e-05	0.000352	CcSEcCtD
Cilazapril—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.19e-05	0.000351	CcSEcCtD
Cilazapril—Urticaria—Irbesartan—type 2 diabetes mellitus	2.18e-05	0.00035	CcSEcCtD
Cilazapril—Shock—Ramipril—type 2 diabetes mellitus	2.18e-05	0.00035	CcSEcCtD
Cilazapril—Headache—Gliclazide—type 2 diabetes mellitus	2.18e-05	0.00035	CcSEcCtD
Cilazapril—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.17e-05	0.000349	CcSEcCtD
Cilazapril—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.17e-05	0.000348	CcSEcCtD
Cilazapril—Tachycardia—Ramipril—type 2 diabetes mellitus	2.17e-05	0.000347	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	2.16e-05	0.00226	CbGpPWpGaD
Cilazapril—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.16e-05	0.000347	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—type 2 diabetes mellitus	2.16e-05	0.00226	CbGpPWpGaD
Cilazapril—Skin disorder—Ramipril—type 2 diabetes mellitus	2.16e-05	0.000346	CcSEcCtD
Cilazapril—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.15e-05	0.000344	CcSEcCtD
Cilazapril—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.13e-05	0.000342	CcSEcCtD
Cilazapril—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.12e-05	0.000339	CcSEcCtD
Cilazapril—Dizziness—Valsartan—type 2 diabetes mellitus	2.12e-05	0.000339	CcSEcCtD
Cilazapril—Anorexia—Ramipril—type 2 diabetes mellitus	2.12e-05	0.000339	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.11e-05	0.00221	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	2.11e-05	0.00221	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.11e-05	0.00221	CbGpPWpGaD
Cilazapril—Dizziness—Orlistat—type 2 diabetes mellitus	2.09e-05	0.000335	CcSEcCtD
Cilazapril—Asthenia—Metformin—type 2 diabetes mellitus	2.09e-05	0.000335	CcSEcCtD
Cilazapril—Hypotension—Ramipril—type 2 diabetes mellitus	2.07e-05	0.000333	CcSEcCtD
Cilazapril—Nausea—Gliclazide—type 2 diabetes mellitus	2.07e-05	0.000332	CcSEcCtD
Cilazapril—Pruritus—Metformin—type 2 diabetes mellitus	2.06e-05	0.000331	CcSEcCtD
Cilazapril—Urticaria—Losartan—type 2 diabetes mellitus	2.06e-05	0.00033	CcSEcCtD
Cilazapril—Abdominal pain—Losartan—type 2 diabetes mellitus	2.05e-05	0.000328	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.04e-05	0.00214	CbGpPWpGaD
Cilazapril—Vomiting—Valsartan—type 2 diabetes mellitus	2.03e-05	0.000326	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—EDN1—type 2 diabetes mellitus	2.03e-05	0.00213	CbGpPWpGaD
Cilazapril—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.03e-05	0.000325	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.02e-05	0.000324	CcSEcCtD
Cilazapril—Rash—Valsartan—type 2 diabetes mellitus	2.02e-05	0.000324	CcSEcCtD
Cilazapril—Dermatitis—Valsartan—type 2 diabetes mellitus	2.02e-05	0.000323	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	2.01e-05	0.00211	CbGpPWpGaD
Cilazapril—Vomiting—Orlistat—type 2 diabetes mellitus	2.01e-05	0.000322	CcSEcCtD
Cilazapril—Insomnia—Ramipril—type 2 diabetes mellitus	2.01e-05	0.000322	CcSEcCtD
Cilazapril—Headache—Valsartan—type 2 diabetes mellitus	2e-05	0.000322	CcSEcCtD
Cilazapril—Diarrhoea—Metformin—type 2 diabetes mellitus	1.99e-05	0.00032	CcSEcCtD
Cilazapril—Rash—Orlistat—type 2 diabetes mellitus	1.99e-05	0.00032	CcSEcCtD
Cilazapril—Paraesthesia—Ramipril—type 2 diabetes mellitus	1.99e-05	0.00032	CcSEcCtD
Cilazapril—Dermatitis—Orlistat—type 2 diabetes mellitus	1.99e-05	0.000319	CcSEcCtD
Cilazapril—Headache—Orlistat—type 2 diabetes mellitus	1.98e-05	0.000318	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—GCG—type 2 diabetes mellitus	1.98e-05	0.00207	CbGpPWpGaD
Cilazapril—Dyspnoea—Ramipril—type 2 diabetes mellitus	1.98e-05	0.000317	CcSEcCtD
Cilazapril—Asthenia—Irbesartan—type 2 diabetes mellitus	1.97e-05	0.000316	CcSEcCtD
Cilazapril—Somnolence—Ramipril—type 2 diabetes mellitus	1.97e-05	0.000316	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.96e-05	0.00205	CbGpPWpGaD
Cilazapril—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.95e-05	0.000313	CcSEcCtD
Cilazapril—Pruritus—Irbesartan—type 2 diabetes mellitus	1.95e-05	0.000312	CcSEcCtD
Cilazapril—Decreased appetite—Ramipril—type 2 diabetes mellitus	1.93e-05	0.000309	CcSEcCtD
Cilazapril—Dizziness—Metformin—type 2 diabetes mellitus	1.93e-05	0.000309	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	1.92e-05	0.000307	CcSEcCtD
Cilazapril—Fatigue—Ramipril—type 2 diabetes mellitus	1.91e-05	0.000307	CcSEcCtD
Cilazapril—Hypersensitivity—Losartan—type 2 diabetes mellitus	1.91e-05	0.000306	CcSEcCtD
Cilazapril—Nausea—Valsartan—type 2 diabetes mellitus	1.9e-05	0.000305	CcSEcCtD
Cilazapril—Constipation—Ramipril—type 2 diabetes mellitus	1.9e-05	0.000304	CcSEcCtD
Cilazapril—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.88e-05	0.000302	CcSEcCtD
Cilazapril—Nausea—Orlistat—type 2 diabetes mellitus	1.88e-05	0.000301	CcSEcCtD
Cilazapril—Asthenia—Losartan—type 2 diabetes mellitus	1.86e-05	0.000298	CcSEcCtD
Cilazapril—Vomiting—Metformin—type 2 diabetes mellitus	1.85e-05	0.000297	CcSEcCtD
Cilazapril—Nateglinide—CYP3A4—type 2 diabetes mellitus	1.85e-05	0.0113	CrCbGaD
Cilazapril—Rash—Metformin—type 2 diabetes mellitus	1.84e-05	0.000295	CcSEcCtD
Cilazapril—Dermatitis—Metformin—type 2 diabetes mellitus	1.84e-05	0.000294	CcSEcCtD
Cilazapril—Pruritus—Losartan—type 2 diabetes mellitus	1.83e-05	0.000294	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.83e-05	0.00192	CbGpPWpGaD
Cilazapril—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.83e-05	0.000293	CcSEcCtD
Cilazapril—Headache—Metformin—type 2 diabetes mellitus	1.83e-05	0.000293	CcSEcCtD
Cilazapril—Dizziness—Irbesartan—type 2 diabetes mellitus	1.82e-05	0.000292	CcSEcCtD
Cilazapril—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.81e-05	0.000291	CcSEcCtD
Cilazapril—Diarrhoea—Losartan—type 2 diabetes mellitus	1.77e-05	0.000284	CcSEcCtD
Cilazapril—Urticaria—Ramipril—type 2 diabetes mellitus	1.76e-05	0.000283	CcSEcCtD
Cilazapril—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.75e-05	0.000281	CcSEcCtD
Cilazapril—Vomiting—Irbesartan—type 2 diabetes mellitus	1.75e-05	0.00028	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.75e-05	0.00183	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.75e-05	0.00183	CbGpPWpGaD
Cilazapril—Rash—Irbesartan—type 2 diabetes mellitus	1.73e-05	0.000278	CcSEcCtD
Cilazapril—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.73e-05	0.000278	CcSEcCtD
Cilazapril—Nausea—Metformin—type 2 diabetes mellitus	1.73e-05	0.000278	CcSEcCtD
Cilazapril—Headache—Irbesartan—type 2 diabetes mellitus	1.72e-05	0.000276	CcSEcCtD
Cilazapril—Dizziness—Losartan—type 2 diabetes mellitus	1.71e-05	0.000274	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.71e-05	0.00179	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	1.71e-05	0.00179	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.7e-05	0.00178	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.7e-05	0.00177	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—type 2 diabetes mellitus	1.69e-05	0.00177	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.69e-05	0.00176	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	1.68e-05	0.00175	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	1.66e-05	0.00174	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—LEP—type 2 diabetes mellitus	1.65e-05	0.00173	CbGpPWpGaD
Cilazapril—Vomiting—Losartan—type 2 diabetes mellitus	1.65e-05	0.000264	CcSEcCtD
Cilazapril—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000262	CcSEcCtD
Cilazapril—Nausea—Irbesartan—type 2 diabetes mellitus	1.63e-05	0.000262	CcSEcCtD
Cilazapril—Rash—Losartan—type 2 diabetes mellitus	1.63e-05	0.000262	CcSEcCtD
Cilazapril—Dermatitis—Losartan—type 2 diabetes mellitus	1.63e-05	0.000261	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.62e-05	0.0017	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.62e-05	0.0017	CbGpPWpGaD
Cilazapril—Headache—Losartan—type 2 diabetes mellitus	1.62e-05	0.00026	CcSEcCtD
Cilazapril—Nateglinide—ALB—type 2 diabetes mellitus	1.61e-05	0.00987	CrCbGaD
Cilazapril—Asthenia—Ramipril—type 2 diabetes mellitus	1.59e-05	0.000255	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.58e-05	0.00166	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.57e-05	0.00165	CbGpPWpGaD
Cilazapril—Pruritus—Ramipril—type 2 diabetes mellitus	1.57e-05	0.000252	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.56e-05	0.00164	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FAS—type 2 diabetes mellitus	1.56e-05	0.00163	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 2 diabetes mellitus	1.54e-05	0.00161	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—C3—type 2 diabetes mellitus	1.54e-05	0.00161	CbGpPWpGaD
Cilazapril—Nausea—Losartan—type 2 diabetes mellitus	1.54e-05	0.000247	CcSEcCtD
Cilazapril—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.52e-05	0.000244	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.49e-05	0.00156	CbGpPWpGaD
Cilazapril—Dizziness—Ramipril—type 2 diabetes mellitus	1.47e-05	0.000235	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.42e-05	0.00148	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	1.42e-05	0.00148	CbGpPWpGaD
Cilazapril—Vomiting—Ramipril—type 2 diabetes mellitus	1.41e-05	0.000226	CcSEcCtD
Cilazapril—Rash—Ramipril—type 2 diabetes mellitus	1.4e-05	0.000224	CcSEcCtD
Cilazapril—Dermatitis—Ramipril—type 2 diabetes mellitus	1.4e-05	0.000224	CcSEcCtD
Cilazapril—Headache—Ramipril—type 2 diabetes mellitus	1.39e-05	0.000223	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.38e-05	0.00144	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.38e-05	0.00144	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	1.37e-05	0.00144	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.36e-05	0.00142	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	1.35e-05	0.00141	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—AGT—type 2 diabetes mellitus	1.33e-05	0.00139	CbGpPWpGaD
Cilazapril—Nausea—Ramipril—type 2 diabetes mellitus	1.32e-05	0.000211	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.32e-05	0.00138	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—LEP—type 2 diabetes mellitus	1.3e-05	0.00136	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—type 2 diabetes mellitus	1.3e-05	0.00136	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.28e-05	0.00134	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.26e-05	0.00132	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP8—type 2 diabetes mellitus	1.2e-05	0.00126	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.17e-05	0.00123	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.17e-05	0.00122	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.16e-05	0.00121	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	1.12e-05	0.00117	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.12e-05	0.00117	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—INS—type 2 diabetes mellitus	1.11e-05	0.00116	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	1.11e-05	0.00116	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	1.09e-05	0.00115	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.09e-05	0.00114	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.08e-05	0.00113	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	1.08e-05	0.00113	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.07e-05	0.00112	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	1.07e-05	0.00112	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	1.07e-05	0.00112	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.04e-05	0.00109	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.04e-05	0.00108	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	9.82e-06	0.00103	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	9.8e-06	0.00103	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.69e-06	0.00101	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.42e-06	0.000986	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP3—type 2 diabetes mellitus	9.11e-06	0.000953	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	9.05e-06	0.000947	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	8.96e-06	0.000937	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—type 2 diabetes mellitus	8.92e-06	0.000934	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.84e-06	0.000925	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.74e-06	0.000915	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	8.73e-06	0.000914	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	8.73e-06	0.000914	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	8.41e-06	0.00088	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	8.41e-06	0.00088	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	8.26e-06	0.000864	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.2e-06	0.000858	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	7.73e-06	0.000809	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	7.7e-06	0.000806	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	7.63e-06	0.000799	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	7.15e-06	0.000748	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	7.12e-06	0.000745	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	7.09e-06	0.000742	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7e-06	0.000733	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	6.9e-06	0.000722	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	6.62e-06	0.000693	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	6.62e-06	0.000693	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.5e-06	0.00068	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	6.22e-06	0.000651	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	6.22e-06	0.000651	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	5.94e-06	0.000621	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	5.9e-06	0.000618	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	5.9e-06	0.000618	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	5.84e-06	0.000611	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	5.74e-06	0.000601	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	5.69e-06	0.000596	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	5.63e-06	0.000589	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	5.48e-06	0.000574	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	5.48e-06	0.000574	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	5.35e-06	0.00056	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	5.32e-06	0.000557	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	5.29e-06	0.000554	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	5.2e-06	0.000544	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	5.2e-06	0.000544	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	5.1e-06	0.000533	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	5.02e-06	0.000525	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	5.02e-06	0.000525	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	5.02e-06	0.000525	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.02e-06	0.000525	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	5.02e-06	0.000525	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	4.86e-06	0.000509	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	4.84e-06	0.000507	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.66e-06	0.000488	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	4.59e-06	0.00048	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	4.59e-06	0.00048	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	4.49e-06	0.00047	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	4.47e-06	0.000468	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.45e-06	0.000466	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	4.27e-06	0.000446	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	4.27e-06	0.000446	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	4.27e-06	0.000446	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.26e-06	0.000446	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	4.2e-06	0.00044	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	4.09e-06	0.000428	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	4.09e-06	0.000428	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	3.94e-06	0.000412	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	3.94e-06	0.000412	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	3.92e-06	0.00041	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	3.87e-06	0.000405	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	3.81e-06	0.000399	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.8e-06	0.000398	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	3.8e-06	0.000398	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	3.8e-06	0.000398	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.68e-06	0.000385	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.66e-06	0.000383	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.63e-06	0.000379	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	3.58e-06	0.000374	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.5e-06	0.000367	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	3.5e-06	0.000366	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	3.43e-06	0.000359	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	3.35e-06	0.00035	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.28e-06	0.000343	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	3.27e-06	0.000342	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	3.23e-06	0.000338	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	3.23e-06	0.000338	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	3.23e-06	0.000338	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	3.23e-06	0.000338	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	3.1e-06	0.000324	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.96e-06	0.000309	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	2.88e-06	0.000302	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.77e-06	0.00029	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.69e-06	0.000282	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	2.64e-06	0.000276	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	2.64e-06	0.000276	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	2.58e-06	0.00027	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	2.57e-06	0.000269	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	2.57e-06	0.000269	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	2.57e-06	0.000269	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.55e-06	0.000267	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.51e-06	0.000262	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	2.48e-06	0.000259	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.43e-06	0.000255	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	2.3e-06	0.000241	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	2.3e-06	0.000241	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	2.3e-06	0.000241	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	2.26e-06	0.000237	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	2.24e-06	0.000235	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.2e-06	0.00023	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.19e-06	0.00023	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.11e-06	0.00022	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.08e-06	0.000218	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.08e-06	0.000218	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.03e-06	0.000213	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	2e-06	0.000209	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	2e-06	0.000209	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.72e-06	0.00018	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.72e-06	0.00018	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.71e-06	0.000179	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.69e-06	0.000177	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.64e-06	0.000172	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.6e-06	0.000167	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.57e-06	0.000164	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.53e-06	0.000161	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.53e-06	0.00016	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.49e-06	0.000156	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.47e-06	0.000154	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.41e-06	0.000148	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.38e-06	0.000145	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.34e-06	0.00014	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.32e-06	0.000138	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.31e-06	0.000137	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.3e-06	0.000136	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.14e-06	0.00012	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.12e-06	0.000117	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.03e-06	0.000108	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	9.84e-07	0.000103	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.84e-07	0.000103	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	9e-07	9.42e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	4.52e-07	4.73e-05	CbGpPWpGaD
